'WORC Break' – Beating the Odds : Engineering the Future of Cardiac Medicine

Mini-hearts with built-in pacemakers. Neuro-cardiac chips. AI-powered phenotyping. This week's WORC Break maps the rapid maturation of cardiac MPS, plus a label-free imaging breakthrough that could change how we watch organoids grow.
'WORC Break' – Beating the Odds : Engineering the Future of Cardiac Medicine
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

'Take 5': Heart of the Matter

This week's Take 5 selection reflects a field advancing rapidly toward physiologically structured, multi-component cardiac platforms, where spatial multi-omics, microphysiological engineering, and label-free imaging are converging to transform how we model, understand, and ultimately treat cardiovascular disease.

A central theme is model innovation guided by developmental biology.  The construction of a modular mini-heart organoid, incorporating stem cell-derived sinoatrial node, atrial, and ventricular domains, exemplifies this shift, using spatial multi-omics of human foetal tissue to reverse-engineer the cardiac conduction hierarchy.  Rather than modelling isolated cell types, such systems recapitulate directional electrical propagation from the sinoatrial node outward, offering an architecturally faithful platform for arrhythmia research and electrophysiology-based drug screening that was not previously achievable.  This developmental blueprint approach, deriving design principles from native human tissue prior to engineering the model, represents a broader methodological maturation in the field.

Disease insight is becoming increasingly mechanistic and multi-system.  A genome-wide association study linking novel genetic loci to sudden cardiac death in young adults used iPSC-derived cardiomyocytes as a functional validation layer, demonstrating how large-scale genomic signals can be translated into mechanistic understanding of ion channel dynamics and arrhythmia risk.  Simultaneously, a compartmentalised neuro-cardiac microphysiological system reveals how sympathetic innervation shapes cardiomyocyte electrophysiology in real time, with pharmacological confirmation of a functional adrenergic relay.  Together, these studies highlight a growing recognition that cardiac pathology cannot be understood in isolation from its genetic architecture or its autonomic context, and that human-relevant models are essential tools for bridging these domains.

Technologically, the field is consolidating around label-free and multi-parametric functional readouts.  Multiparametric dynamic optical coherence tomography (MP-DOCT) offers a compelling, non-invasive framework for quantifying beating dynamics and contractile parameters in cardiac organoids, detecting beat-to-beat heterogeneity (including patterns consistent with cardiac alternans), that conventional averaged readouts would obscure.  This kind of cycle-by-cycle resolution is precisely what is needed for meaningful cardiotoxicity assessment.  Alongside this, AI-assisted workflows for image-based phenotyping and virtual fluorescence labelling are emerging as essential tools for scaling 3D cardiac platforms toward high-throughput screening, addressing one of the field's persistent bottlenecks.

Translation is fast becoming structurally embedded in model design.  Patient-iPSC-derived constructs are now successfully recapitulating genetic cardiomyopathies and enabling drug responses that better reflect clinical plasma concentrations.  Yet four interconnected barriers – cardiomyocyte maturity, functional vascularisation, cross-laboratory standardisation, and GMP-compliant manufacturing – remain central challenges that the field must address systematically if personalised cardiac medicine is to become a near-term reality.

Overall, this week's selection signals a decisive maturation in cardiac MPS, from isolated cell assays to integrated, architecturally coherent human systems capable of capturing the full complexity of cardiac physiology, disease, and therapeutic response.


Source Articles:

Science and Technology Review Publishing House (2026) Advanced 3D heart models could transform cardiovascular drug discovery. NewsMedical.net; https://www.news-medical.net/news/20260510/Advanced-3D-heart-models-could-transform-cardiovascular-drug-discovery.aspx

Chang  Liu, Jing  Guo, Gunash  Mirzayeva, Michail  Spanos, Ruoting  Teng, Guoping  Li, Dragos  Cretoiu, Zhaoyang  Chen and Junjie  Xiao (2026) 3D Cardiac Constructs in Drug Discovery: Current Advances and Future Challenges. Research; https://www.worc.community/documents/advanced-3d-heart-models-could-transform-cardiovascular-drug-discovery

Jiajun Zhu, Zhaowei Han, Roberto De Gregorio, Kevin Chang , Zheyu Zhang, Xue Dong, Kalpita Banerjee, Kai Liu, Martha Rea-Moreno, Mikal Kizilbash, Alicia Alonso, Jie Liu, Su-Yi Tsai, Ya-Wen Chen, Todd Evans & Shuibing Chen (2026) Engineering a pacemaker-driven human mini-heart guided by spatial multi-omics of sinoatrial node development. bioRxiv; https://www.worc.community/documents/engineering-a-pacemaker-driven-human-mini-heart-guided-by-spatial-multi-omics-of-sinoatrial-node-development

Jean-Baptiste Reisqs, Yvonne Sleiman & Mohamed Boutjdir (2026) Modelling Sympathetic Neuro-Cardiac Interactions in a hiPSC-Based Microphysiological System. bioRxiv; https://www.worc.community/documents/modelling-sympathetic-neuro-cardiac-interactions-in-a-hipsc-based-microphysiological-system

Ruhr-Universitaet-Bochum (2026) New genetic link found for sudden cardiac death in young people. NewsMedical.net; https://www.news-medical.net/news/20260508/New-genetic-link-found-for-sudden-cardiac-death-in-young-people.aspx

Nchumpeni Chonpemo Shitiri, Thanh Dat Le, Soo Ji Yoo, Meeyoung Cho, Yong Sook Kim, Youngkeun Ahn & Changho Lee (2026) Multiparametric dynamic optical coherence tomography for evaluation of human cardiac organoids subjected to external stress. Biomedical Optical Express; https://www.worc.community/documents/multiparametric-dynamic-optical-coherence-tomography-for-evaluation-of-human-cardiac-organoids-subjected-to-external-stress


'Tech Highlight': No Labels, No Limits – Programmable Spatial Coherence and the Next Frontier in Organoid Imaging

A persistent tension in organoid biology is that the most powerful imaging tools often impose the greatest biological burden.   Fluorescent labelling introduces phototoxicity; live imaging over days demands repeated excitation that bleaches markers and stresses cells; interferometric methods require elaborate optical alignment that limits practical use.   A preprint from researchers at the Korean Advanced Institute of Science and Technology (KAIST) proposes a substantive rethinking of this trade-off, introducing programmable spatial coherence tomography (PSCT); a label-free, volumetric reflection imaging method that achieves diffraction-limited 3D resolution under single-wavelength, monochromatic illumination.

Conventional optical coherence tomography (OCT) achieves depth sectioning by exploiting broadband temporal coherence, using short-coherence-length light sources to gate reflections from specific axial planes.   While effective, this approach demands broadband light sources, stringent path-length matching, and symmetric interferometric geometries that are difficult to integrate with standard laboratory microscopes.   PSCT takes a fundamentally different route.  Rather than gating light in time, it engineers spatial coherence by dynamically modulating the illumination pupil using a digital micromirror device.   A sequence of coded pupil patterns introduces redundancy in Fourier space sampling, and this redundancy is exploited computationally to jointly retrieve aberrations, illumination profiles, and sample motion, without guide stars, modal assumptions, or path-length constraints.

The practical result is a simplified single-objective geometry that replaces conventional Linnik and Mirau interferometers.   Each volumetric acquisition covers an 80 × 80 × 100 µm³ field in approximately 9 seconds, with resolution approaching the theoretical diffraction limit (249 × 238 × 876 nm³ after aberration correction, versus a theoretical limit of 230 × 230 × 810 nm³).   Critically, the self-calibration framework simultaneously corrects for optical aberrations, accounts for misalignments, and stabilises physiological motion during acquisition.  A feature that proves particularly valuable in live samples where cellular and respiratory movement would otherwise degrade image quality.

For the organoid and microphysiological systems community, the most compelling demonstrations involve hepatic organoids monitored longitudinally over 48 hours at 12-hour intervals.   PSCT resolved lumen growth, cell boundary thickening, nuclear organisation, and the emergence of cell polarity, distinguishing healthy organoids undergoing normal maturation from those displaying abnormal morphology and lumen collapse, all without a single fluorescent label and without evidence of phototoxic disturbance.   A dynamic imaging mode, exploiting PSCT's computational refocusing capability, further resolved subcellular compartments by their characteristic motility, distinguishing cytoplasm, nuclei, tricellular junctions, and lumen contents based on frequency-resolved motion signatures rather than molecular specificity.

The broader applicability of PSCT was demonstrated across diverse specimen types: large-area histological sections of human colon cancer tissue, fixed hepatic organoids, live mouse oocytes, and in vivo mouse brain imaged through a thinned-skull cranial window.   In each case the system delivered cellular-resolution volumetric contrast without fluorescence, with aberration and motion correction restoring structural detail that was lost in raw acquisitions.

The authors note that PSCT's current penetration depth is limited to approximately 100 µm, a constraint that could be extended through longer wavelengths or lower numerical aperture at the cost of lateral resolution.   However, within the depth range typical of organoid and microphysiological systems, the method is well matched to experimental needs.   Its single-objective design is explicitly positioned as a candidate for integration as a plug-in module on standard inverted microscopes, a step that could make label-free volumetric imaging a routine, parallel complement to existing fluorescence workflows rather than a specialist instrument requirement.

In establishing that temporal coherence is not required for volumetric reflection imaging, PSCT offers a genuinely new tool for long-term live organoid studies, one where structural dynamics, functional contrast, and morphological phenotyping can be accessed without the biological and operational costs of labelling.


Source Article:

Hervé Hugonnet, Jieun Choi, Gyoung Hwan Kim, Chulmin Oh, Jimin Cho, Chungha Lee, Su-Jin Shin, Sujin Park, Bon-Kyoung Koo, Wang-Yuhl Oh, Pilhan Kim & YongKeun Park  (2026) Programmable spatial coherence tomography: diffraction-limited three-dimensional reflection imaging under modulated monochromatic illumination. arXiv; https://www.worc.community/documents/programmable-spatial-coherence-tomography-diffraction-limited-three-dimensional-reflection-imaging-under-modulated-monochromatic-illumination


Welcome to the WORC Break!  A fresh weekly feature combining Take 5 and the Tech Highlight into a fast, engaging 10-minute spotlight on all things organoid.  To make sure you don’t miss it, please log into your account and update your notification preferences.  Please share it, give feedback, and join the discussion - I hope you enjoy it!

Please sign in or register for FREE

If you are a registered user on WORC.Community, please sign in